Market Place
Sourcing Support
Vericel to Present at Multiple Upcoming Investor Conferences
04 Mar 2025 //
GLOBENEWSWIRE
Vericel Reports 2024 Financial Results
27 Feb 2025 //
GLOBENEWSWIRE
Vericel to Report Q4 & Full-Year 2024 Financial Results on Feb 27
13 Feb 2025 //
GLOBENEWSWIRE
Vericel Announces Preliminary Results, 2025 Guidance, & Profit Goal
14 Jan 2025 //
GLOBENEWSWIRE
Vericel to Present at Annual J.P. Morgan Healthcare Conference
08 Jan 2025 //
GLOBENEWSWIRE
Vericel Reports Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Vericel To Report Q3 2024 Financial Results On Nov 7
24 Oct 2024 //
GLOBENEWSWIRE
Vericel to Present at Morgan Stanley Global Healthcare Conference Sept 6
29 Aug 2024 //
GLOBENEWSWIRE
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
26 Aug 2024 //
GLOBENEWSWIRE
Vericel Announces FDA Approval Of NexoBrid For Pediatric Severe Burns
15 Aug 2024 //
GLOBENEWSWIRE
Vericel To Present At Canaccord Genuity Growth Conference On August 14
07 Aug 2024 //
GLOBENEWSWIRE
Vericel Reports Second Quarter 2024 Financial Results
01 Aug 2024 //
GLOBENEWSWIRE
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
22 Jul 2024 //
GLOBENEWSWIRE
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
18 Jul 2024 //
GLOBENEWSWIRE
Vericel to Present at the Truist Securities MedTech Conference on Tue, 2024
11 Jun 2024 //
GLOBENEWSWIRE
Vericel To Present At Leerink Healthcare Conference
22 May 2024 //
GLOBENEWSWIRE
Vericel Q1 2024 Results, Raises FY2024 Guidance
08 May 2024 //
GLOBENEWSWIRE
BriaCell Announces Oral and Poster Presentations at ASCO 2024
24 Apr 2024 //
GLOBENEWSWIRE
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
24 Apr 2024 //
GLOBENEWSWIRE
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Vericel to Present at the TD Cowen 44th Annual Health Care Conference
27 Feb 2024 //
GLOBENEWSWIRE
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results
15 Feb 2024 //
GLOBENEWSWIRE
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference
05 Feb 2024 //
GLOBENEWSWIRE
Vericel Announces Full-Year and Fourth Quarter 2023 Financial Results
09 Jan 2024 //
GLOBENEWSWIRE
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Vericel Reports Third Quarter 2023 Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Vericel to Present at the Stephens Annual Investment Conference
07 Nov 2023 //
GLOBENEWSWIRE
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
25 Oct 2023 //
GLOBENEWSWIRE
Vericel Announces Publication of Positive Results from Phase 3 Debride Study
28 Sep 2023 //
GLOBENEWSWIRE
Vericel Announces U.S. Commercial Availability of NexoBrid
20 Sep 2023 //
GLOBENEWSWIRE
Vericel to Present at the Morgan Stanley Global Healthcare Conference
06 Sep 2023 //
GLOBENEWSWIRE
Vericel Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
GLOBENEWSWIRE
Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023
20 Jul 2023 //
GLOBENEWSWIRE
Vericel Reports 1Q 2023FYR &Raises Full-Year 2023 Financial Guidance
10 May 2023 //
GLOBENEWSWIRE
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference
28 Feb 2023 //
GLOBENEWSWIRE
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023
09 Feb 2023 //
GLOBENEWSWIRE
Vericel Announces Preliminary Fourth-Quarter & Full-Year 2022 Financial Results
10 Jan 2023 //
GLOBENEWSWIRE
Vericel Announces FDA Approval of NexoBrid for Severe Thermal Burns in Adults
29 Dec 2022 //
GLOBENEWSWIRE
Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022
26 Oct 2022 //
GLOBENEWSWIRE
Vericel to Present at the Ladenburg Thalmann Healthcare Conference
22 Sep 2022 //
GLOBENEWSWIRE
Vericel to Present at the Morgan Stanley Global Healthcare and H.C. GICs
06 Sep 2022 //
GLOBENEWSWIRE
Vericel Announces Publication of +ve Results from Retrospective Study by Burn
21 Jul 2022 //
GLOBENEWSWIRE
Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022
20 Jul 2022 //
GLOBENEWSWIRE
Vericel Reports First Quarter 2022 Financial Results
04 May 2022 //
GLOBENEWSWIRE
Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022
20 Apr 2022 //
GLOBENEWSWIRE
Wave Life Sciences: RNA Base Editing Modality and Alpha-1 ATP Deficiency Program
15 Mar 2022 //
GLOBENEWSWIRE
Vericel to Present at Cowen 42nd Annual Health Care Conference on March 9, 2022
01 Mar 2022 //
GLOBENEWSWIRE
Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer
24 Feb 2022 //
GLOBENEWSWIRE
Vericel Reports Q4 and Full-Year 2021 Financial Results
24 Feb 2022 //
PRESS RELEASE
Vericel to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 Jan 2022 //
GLOBENEWSWIRE
Vericel Expands Executive Leadership Team & Appoints Patrick Fowler as Senior VP
07 Sep 2021 //
GLOBENEWSWIRE
Vericel to Present at Ladenburg Thalmann Healthcare Conference on July 13, 2021
07 Jul 2021 //
GLOBENEWSWIRE
Vericel Provides Regulatory Update for NexoBrid
29 Jun 2021 //
GLOBENEWSWIRE
MediWound & Vericel Announce Acceptance of the First Delivery NexoBrid to BARDA
25 Aug 2020 //
PRESS RELEASE
